Joint Filing AgreementJoint Filing Agreement • April 25th, 2006 • Albert & Margaret Alkek Foundation • Pharmaceutical preparations
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.
